• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
One-year cardiovascular outcomes after GLP-1 discontinuation

One-year cardiovascular outcomes after GLP-1 discontinuation

by Truveta staff | Sep 3, 2025 | Research

Data Overview Clinical notes Images Mother-child Oncology Regulatory grade Truveta Language Model Truveta Studio Genomics Solutions Life science Public health Healthcare Research Resources About Blog Members Leadership Events & webinars Newsroom Careers Get...
De-risking clinical programs using data from EHRs: an example from medtech

De-risking clinical programs using data from EHRs: an example from medtech

by Truveta staff | Oct 2, 2023 | Data

In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making it essential for leaders to de-risk their clinical programs. Having access to a...

Share this


Recent posts

  • Truveta experts: Gestational diabetes screening in real-world practice
  • Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data
  • Johns Hopkins builds research community to explore new frontiers in health using Truveta Data

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.